Interleukin-16 for the gene therapy of HIV infection

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.12, 1997-12, pp. : 1879-1882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene therapy for HIV infection

By Chadwick D.R. Lever A.M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 983-990

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy Approaches to HIV Infection

By Lori F.

American Journal of PharmacoGenomics, Vol. 2, Iss. 4, 2002-01 ,pp. : 245-252

Adis International

Access to resources Recommend Favorite

Gene Therapy Approaches to HIV Infection

Pharmaceutical Innovation, Vol. 12, Iss. 2, 2003-02 ,pp. : 33-36

Adis International

Access to resources Recommend Favorite

Lentiviral Vectors for Gene Therapy of HIV-1 Infection

Current Gene Therapy, Vol. 2, Iss. 1, 2002-02 ,pp. : 23-43

Bentham Science Publishers

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Interleukin-2 as an Adjunct to Antiviral Therapy in HIV Infection

By Piscitelli S.C.

Drug Safety, Vol. 22, Iss. 1, 2000-01 ,pp. : 19-31

Adis International

Access to resources Recommend Favorite